Kimberly Brown
Kimberly Brown
Exploring the Use of Digital Therapeutics for Patients With Disorders of Gut-Brain Interaction [0.03%]
探究数字疗法在肠道脑交互障碍患者中的应用
Gary R Lichtenstein
Gary R Lichtenstein
Sanjana Rao,Sean-Patrick Prince,Sirisha Gaddipati et al.
Sanjana Rao et al.
Hepatocellular carcinoma (HCC) remains a leading cause of cancer-related deaths worldwide. Despite the decreasing prevalence of hepatitis C, the burden of HCC is expected to rise owing to the increasing prevalence of metabolic syndrome and ...
The Promise of Digital Therapeutics for Disorders of Gut-Brain Interaction [0.03%]
数字疗法在肠脑相互作用障碍中的前景
Kyle Staller
Kyle Staller
Louis J Cohen
Louis J Cohen
From Past to Present: The Evolution of Pharmacologic Therapies for Eosinophilic Esophagitis [0.03%]
从过去到现在：嗜酸细胞性食管炎药物治疗的演变历程
Susie Min,Joy W Chang
Susie Min
Within the evolving landscape of eosinophilic esophagitis (EoE) management are multiple pharmacologic treatment modalities, including proton pump inhibitors (PPIs), swallowed topical corticosteroids, and novel biologic agents. Studies to da...